Showing results (11-20 of 152) with videos related to
Sort By:
Pageof 16
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 23, 2003
Respiratory failure due to bilateral diaphragm palsy as an early manifestation of ALSAdam Czapliński, Werner Strobel, Claudio Gobbi, et al.Neuropharmacology|January 14, 2014
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis modelDaniel C Anthony, Nicola R Sibson, Patrick Losey, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 3, 2021
Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple SclerosisJay Roodselaar, Yifan Zhou, David Leppert, et al.Journal of Neuroinflammation|October 8, 2020
Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitisNgoc Dung Le, Lukas Muri, Denis Grandgirard, et al.Multiple Sclerosis and Related Disorders|February 8, 2021
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTIMaija Saraste, Svetlana Bezukladova, Markus Matilainen, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 23, 2019
Low-Dose Subcutaneous Anti-CD20 Treatment Depletes Disease Relevant B Cell Subsets and Attenuates NeuroinflammationCatherine Huck, David Leppert, Vanessa Wegert, et al.Journal of Neuroimmunology|October 7, 2009
AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritisZhi-Yuan Zhang, Zhiren Zhang, Caroline Zug, et al.Acta Neuropathologica|December 10, 2002
Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathiesSusanne Renaud, Beat Erne, Peter Fuhr, et al.Journal of Neuroimmunology|February 2, 2010
A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain proteinJens Kuhle, Axel Regeniter, David Leppert, et al.CNS Drugs|December 17, 2011
Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosisHenrik Gensicke, David Leppert, Özgür Yaldizli, et al.Pageof 16